AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2016
May 26, 2016
30826_dirs_2016-05-26_8dc1b8f3-42c2-4fb5-9980-9c9e1eaeb747.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2016-05-24
Reporting Person: Benjamin Howard (VP Business Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-24 | Common stock | M | 10000 | $6.23 | Acquired | 28626 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-05-24 | Stock Option (Right to Buy) | $6.23 | M | 10000 | Disposed | 2023-02-28 | Common Stock (10000) | Direct |
Footnotes
F1: 10,000 options vest and become exercisable on the following dates: 2/28/2014, 2/28/2015, 2/28/2016, 2/28/2017
More from REPLIGEN CORP
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 6
Earnings Release
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23